Spontaneous immune rejection of intraocular tumors in mice
- PMID: 3924853
Spontaneous immune rejection of intraocular tumors in mice
Abstract
The growth and spontaneous resolution of syngeneic intraocular tumors were studied in DBA/2 mice. The P91 mutant clone of P815 mastocytoma (DBA/2 origin) expresses potent tumor-specific transplantation antigens (TSTA) that elicit vigorous immune responses in the syngeneic host. P91 tumors grew transiently and underwent spontaneous resolution following intracameral transplantation in DBA/2 hosts. The spontaneous rejection of the intraocular P91 tumors was a T-cell-dependent, radiosensitive immune process since these tumors grew progressively in T-cell-deficient nude mice and sublethally x-irradiated DBA/2 hosts. Intraocular P91 tumors induced vigorous cytotoxic T-lymphocyte (CTL), antibody, and delayed-type hypersensitivity (DTH) responses in immunocompetent DBA/2 hosts. The acquisition of DTH and CTL reactivity against the TSTA on the intraocular P91 tumors coincided with the onset of spontaneous rejection and suggested a pivotal role for cellular immune mechanisms in the destruction of the primary intraocular neoplasms. Moreover, histopathologic features attending tumor regression were compatible with the DTH reaction in the mouse. Tumor regression was associated with extensive vascular margination and emigration of neutrophils among viable tumor cells at the interface of the tumor mass and uveal components. Areas of previous tumor growth were replaced by a bed of granulation tissue accompanied by a mixed inflammatory infiltrate. Although immunocompetent hosts were able to rid their eyes of tumor, all of the eyes eventually became phthisical. The present findings are consistent with the hypothesis that cellular immune processes play a major role in the spontaneous rejection of intraocular tumors.
Similar articles
-
Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.J Immunol. 1987 Jun 15;138(12):4515-23. J Immunol. 1987. PMID: 3108394
-
Immune rejection of metastases arising from intraocular tumors in mice.Invest Ophthalmol Vis Sci. 1986 Sep;27(9):1355-61. Invest Ophthalmol Vis Sci. 1986. PMID: 3091527
-
Histopathologic analysis of intraocular allogeneic tumors in mice.Invest Ophthalmol Vis Sci. 1985 Oct;26(10):1368-76. Invest Ophthalmol Vis Sci. 1985. PMID: 3930419
-
The immunopathology of intraocular tumour rejection.Eye (Lond). 1991;5 ( Pt 2):186-92. doi: 10.1038/eye.1991.33. Eye (Lond). 1991. PMID: 2070879 Review.
-
Immunoregulation of intraocular tumours.Eye (Lond). 1997;11 ( Pt 2):249-54. doi: 10.1038/eye.1997.60. Eye (Lond). 1997. PMID: 9349421 Review.
Cited by
-
CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination.J Immunol. 2010 Dec 1;185(11):6706-18. doi: 10.4049/jimmunol.0903411. Epub 2010 Nov 1. J Immunol. 2010. PMID: 21041723 Free PMC article.
-
Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.Cancer Res. 2011 Apr 1;71(7):2445-54. doi: 10.1158/0008-5472.CAN-10-2628. Epub 2011 Feb 9. Cancer Res. 2011. PMID: 21307132 Free PMC article.
-
Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.Immunology. 1992 Oct;77(2):189-95. Immunology. 1992. PMID: 1427974 Free PMC article.
-
IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.J Immunol. 2011 Oct 15;187(8):4219-28. doi: 10.4049/jimmunol.1100826. Epub 2011 Sep 14. J Immunol. 2011. PMID: 21918192 Free PMC article.
-
Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.Immunology. 1996 Sep;89(1):34-40. doi: 10.1046/j.1365-2567.1996.d01-714.x. Immunology. 1996. PMID: 8911137 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical